Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.
about
Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strainsStructural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharideLaboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein AImmunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide.Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitroHigh-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.Polysaccharide antigens of Pseudomonas aeruginosa.Pseudomonas aeruginosa infection in cancer patients.Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionateSynthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates.Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A.Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa.Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A.Effect of Pseudomonas aeruginosa cytotoxin on thymidine incorporation by murine splenocytes.Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosaToxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives.Antibody response to Pseudomonas aeruginosa exoproducts in cancer patientsCloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli.Effects of immobilized immune complexes on Fc- and complement-receptor function in resident and thioglycollate-elicited mouse peritoneal macrophages.Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV.Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients.
P2860
Q30423024-B1318692-E1C2-4498-9241-D6050C847BF3Q30435195-D1428845-FE7C-433A-940A-9744752034C1Q30453151-F7D8F1E1-54E2-42F6-BB9F-A0450B7352CAQ33757770-E48AC2D4-ECCD-4545-A786-F86700050C97Q34520993-27D3D718-68B3-458C-A4B7-8DE14E5E0ABBQ34526987-EB3B0048-53C9-4684-A239-8F1B988337D7Q34532344-AA4FC172-2A4E-4AFA-B9CC-6BE4CD34DC71Q34535624-CBAB54DA-AF20-4C21-B2ED-453258EE8C8EQ35090330-526124CE-7450-401E-B9A6-563FA06B14F9Q35207720-EF5FD04B-4600-47FE-BCEE-4DDA29554D7CQ35377220-4692A5DB-83DB-4EBC-AA62-C810DDEEDD1AQ35451387-9A754A98-F2D9-416D-A8B5-A0DA69587E0AQ35575338-320166BD-C34C-4B62-A3B0-1A991FE8B8E9Q35775764-35DD2D52-F051-40A2-816E-9197DAC37AEFQ36335435-8B151891-FA99-4F40-AC17-C0EA25A083E0Q36430463-EB32BF4E-2BC3-47DB-A8B5-6C4D6E53007CQ36447316-53083634-AA73-4DDE-9B2D-9222BBCDDFEBQ36597493-0CFFCEEB-B547-4E1E-8E05-E3687A01577BQ36756527-9B30B7AB-3D86-46AE-9B10-6A3B6435016CQ36958120-2B33A6E3-C82F-4CC2-85D4-C8A7A4BF8542Q36985988-A363ECB0-FDA4-459C-A2EA-8CACBF425750Q37020499-3191F866-8915-4830-961F-B91FE0F46F99Q37026057-57AFBB0E-F59C-499E-B78B-8AFFD6A9CBE7Q37027388-B2EFB7D4-CF4C-4564-9C5F-80CC0C80CDF7Q37054015-9D768E4D-D638-4A63-887E-A81C0935E7DCQ37075805-84AA9A42-C098-43EA-85BF-D4AA82775562Q37077778-56EB421D-D74D-44B9-A3D6-A5FD34818721Q37079224-2BE2FF65-E878-45BD-99E4-8CF00FA79FACQ37082099-9E3CF076-46EB-4C7F-819E-9B061BAE8B64Q37097592-BF06B2D4-D14A-4816-A690-EC4406334F5AQ37287848-AD88698E-AEF3-483E-89B7-552383452688Q37294311-A92E4C56-893E-4363-A4C2-1A2D0E49DD0DQ39806854-CB13FA71-763B-405A-A29A-99A081EC0D1FQ40149473-851209E9-21F7-483A-BD19-3A2ACA87990EQ40157040-464D1F68-F536-4035-B369-05117F087112Q40158359-E4B96CD4-8130-4A02-8DBC-08FD539638EDQ40172509-09A82306-6FE1-43D6-A7C5-2858087ED7EEQ40181441-250E30A7-74BA-4544-900C-2A175CB2D253Q40199797-AC40212F-C2E7-40DA-9124-CD431276DB53Q40216514-1ED1E774-3770-4EEC-BDDB-9AFE6F1DE3FA
P2860
Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protective activity of antibod ...... aeruginosa septicemia in man.
@en
Protective activity of antibod ...... aeruginosa septicemia in man.
@nl
type
label
Protective activity of antibod ...... aeruginosa septicemia in man.
@en
Protective activity of antibod ...... aeruginosa septicemia in man.
@nl
prefLabel
Protective activity of antibod ...... aeruginosa septicemia in man.
@en
Protective activity of antibod ...... aeruginosa septicemia in man.
@nl
P2860
P921
P356
P1476
Protective activity of antibod ...... aeruginosa septicemia in man.
@en
P2093
P2860
P304
P356
10.1172/JCI109300
P407
P577
1979-02-01T00:00:00Z